Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Neurones SA
PAR:NRO

Watchlist Manager
Neurones SA Logo
Neurones SA
PAR:NRO
Watchlist
Price: 34.5 EUR 0.29%
Market Cap: €839.4m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
+26%
5Y
+39%
10Y
+120%
Liabilities
+
3Y
+33%
5Y
+65%
10Y
+154%
Equity
+
3Y
+20%
5Y
+22%
10Y
+96%

Balance Sheet Decomposition
Neurones SA

Balance Sheet
Neurones SA

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
3
5
6
9
51
48
57
55
60
69
76
87
99
122
130
129
146
170
215
261
261
270
269
43
Cash
0
0
0
0
0
0
0
0
18
22
15
21
18
40
53
66
71
95
95
138
92
74
26
43
Cash Equivalents
3
5
6
9
51
48
57
55
42
47
60
67
81
82
77
63
75
75
120
123
170
195
243
0
Short-Term Investments
33
32
35
38
0
0
0
0
0
0
0
0
0
0
0
11
7
3
3
5
173
197
271
276
Total Receivables
26
27
26
30
34
46
53
67
63
75
101
111
127
128
149
173
186
202
186
176
190
225
236
250
Accounts Receivables
24
24
22
27
28
37
43
56
50
60
76
85
91
92
102
121
127
134
131
129
137
165
174
178
Other Receivables
2
3
3
4
5
9
10
11
13
15
25
27
36
36
47
52
59
68
55
46
53
60
63
73
Inventory
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
1
1
0
1
0
Other Current Assets
0
0
0
0
0
0
0
0
2
2
3
3
3
3
4
5
6
8
8
7
9
10
12
18
Total Current Assets
62
63
67
77
84
95
110
122
126
145
179
202
229
254
284
319
346
383
413
449
464
507
546
588
PP&E Net
2
2
2
2
2
2
3
4
4
4
6
6
8
8
15
14
16
16
47
47
46
49
59
61
PP&E Gross
2
2
2
2
2
2
3
4
4
4
6
6
8
8
15
14
16
16
47
47
46
49
59
61
Accumulated Depreciation
2
3
3
4
5
5
6
6
7
9
12
14
15
19
23
27
31
37
50
61
70
59
96
105
Intangible Assets
0
2
2
2
1
0
1
1
1
0
1
0
0
0
2
2
1
0
0
1
1
1
1
2
Goodwill
10
12
11
11
14
19
21
35
34
35
36
37
37
36
38
43
41
40
40
43
45
45
52
57
Long-Term Investments
1
1
1
1
1
1
1
4
4
4
2
3
3
4
11
6
6
7
7
8
8
10
11
12
Other Long-Term Assets
0
0
0
0
1
2
1
1
1
2
2
2
2
2
2
2
2
2
3
3
3
5
6
7
Other Assets
10
12
11
11
14
19
21
35
34
35
36
37
37
36
38
43
41
40
40
43
45
45
52
57
Total Assets
75
N/A
79
+6%
82
+4%
93
+12%
101
+9%
118
+17%
136
+15%
166
+22%
169
+2%
190
+12%
226
+19%
250
+11%
279
+11%
304
+9%
351
+15%
386
+10%
412
+7%
449
+9%
510
+14%
550
+8%
568
+3%
616
+9%
674
+9%
726
+8%
Liabilities
Accounts Payable
25
24
22
28
29
38
44
61
11
11
15
16
19
17
30
26
29
31
31
33
38
43
44
58
Accrued Liabilities
0
0
0
0
0
0
0
0
44
50
62
69
73
75
81
90
90
92
92
94
103
115
125
129
Short-Term Debt
0
0
0
0
0
0
0
2
1
0
0
0
0
0
0
1
0
0
0
0
0
0
2
0
Current Portion of Long-Term Debt
2
0
1
0
1
0
0
0
0
0
0
0
0
0
1
1
1
0
7
7
7
8
11
12
Other Current Liabilities
0
0
0
0
1
1
3
4
5
7
9
9
11
14
20
27
22
28
26
28
36
41
47
53
Total Current Liabilities
26
25
23
28
30
39
48
67
60
68
86
94
103
107
133
145
142
152
156
161
185
207
229
253
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
1
0
0
25
27
28
27
31
29
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Minority Interest
1
1
2
2
2
3
3
6
6
7
10
11
13
16
17
21
25
29
30
36
41
45
54
58
Other Liabilities
0
0
0
0
0
2
2
2
0
0
0
0
1
1
1
1
1
1
2
2
3
6
6
7
Total Liabilities
27
N/A
26
-4%
25
-4%
30
+21%
32
+7%
44
+37%
53
+19%
74
+41%
67
-10%
76
+13%
96
+27%
106
+10%
117
+10%
124
+6%
153
+24%
169
+10%
169
+0%
182
+8%
213
+17%
227
+7%
256
+13%
286
+11%
320
+12%
348
+9%
Equity
Common Stock
9
9
9
9
9
9
9
9
9
9
9
10
10
10
10
10
10
10
10
10
10
10
10
10
Retained Earnings
10
15
20
25
30
35
43
54
62
74
89
104
121
140
157
176
202
226
256
282
270
289
313
352
Additional Paid In Capital
29
29
29
29
29
30
30
28
30
31
31
31
31
31
31
31
31
31
31
31
31
31
31
16
Total Equity
47
N/A
53
+12%
57
+9%
62
+9%
69
+10%
74
+8%
83
+12%
91
+11%
102
+12%
114
+12%
129
+13%
144
+11%
162
+12%
181
+12%
198
+10%
217
+9%
243
+12%
267
+10%
297
+11%
323
+9%
312
-3%
331
+6%
354
+7%
378
+7%
Total Liabilities & Equity
75
N/A
79
+6%
82
+4%
93
+12%
101
+9%
118
+17%
136
+15%
166
+22%
169
+2%
190
+12%
226
+19%
250
+11%
279
+11%
304
+9%
351
+15%
386
+10%
412
+7%
449
+9%
510
+14%
550
+8%
568
+3%
616
+9%
674
+9%
726
+8%
Shares Outstanding
Common Shares Outstanding
23
23
23
23
23
23
23
23
23
23
24
24
24
24
24
24
24
24
24
24
24
24
24
24

See Also

Summary
NRO intrinsic value, competitors valuation, and company profile.
DCF Valuation
NRO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NRO stock valuation using valuation multiples.
Wall Street Estimates
NRO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NRO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 318,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.